Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce

Regulations by 2FIRSTS, edited by Sophia
May.05.2024
Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce
Vietnam debates whether to ban or regulate e-cigarettes due to potential health risks and widespread use among youth.

According to Vietnamese media outlet Viettimes, on May 4th, the issue of whether to ban or regulate e-cigarettes was discussed in the National Assembly by the Social Affairs Committee and the National Assembly's Committee on Cultural Education to address concerns about the harm caused by e-cigarettes and heated tobacco products.

 

Deputy Minister of Health Dao Honglan stated that the Ministry of Health has already done a lot of work, providing advice to the national management through evidence and impact assessment in order to revise the Tobacco Harmful Effects Law and make plans. Minister of Industry and Trade Pan Sheng proposed piloting management of e-cigarettes.

 

Faced with the conflicting views of the Ministry of Health and the Ministry of Industry and Commerce on e-cigarettes, representatives in Congress raised pointed questions.

 

The Vice Chairman of the Vietnamese National Assembly, Tran Thanh Man, expressed concerns about the increasing prevalence of e-cigarette use, especially among young people, teenagers, and students, which are gradually replacing traditional tobacco. He emphasized that the health risks of e-cigarettes are similar to traditional tobacco, particularly the harm they pose to the brain development of children and adolescents, leading to addiction, cognitive and emotional disorders, reduced learning abilities, and psychological obstacles. E-cigarettes also have a negative impact on the quality of human resources, affecting social order and economic and social development.

 

Vice Chairperson of the Cultural and Education Committee, Ms. Ruan Mei, calls for clarity on the boundaries between the economic benefits of e-cigarettes and the negative impacts on health costs.

 

Speaking at the conference, Dr. Nguyen Vinh Chi firmly stated, "I find it strange, why test addictive substances, especially such deadly substances. There is absolutely no need for any testing! Because e-cigarettes have already proliferated globally and in Vietnam, their harm is widely recognized... As a doctor, I question whether anyone can find any benefits of this e-cigarette!"

 

Dao Honglan emphasized that e-cigarettes and heated tobacco products pose great risks to human health, and therefore should be banned from the start rather than being allowed on the market before becoming unmanageable. Even with the various current methods of e-cigarette regulation, the question of whether they can be effectively managed is a concerning issue. Who will be responsible for people's lives? Especially when around 40,000 people die from smoking each year.

 

Deputy Director Chen Ruanquan, of the Legal and Administrative Reform Department of the Ministry of Public Security, shares the same view as the Ministry of Health, believing that e-cigarettes pose a harm to human health, particularly for young people. He maintains that this product not only harms human health but also the economy. In particular, individuals who have been convicted of drug offenses are increasingly using e-cigarettes to soak and mix drugs.

 

Teenage use of e-cigarettes is widespread. People are always seen using e-cigarettes while waiting at red lights on the streets. This trend is growing at a concerning rate, so the harms of e-cigarettes outweigh the expected economic and social benefits, according to Rear Admiral Chen Ruanquan.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20